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ABSTRACT
Caffeine is consumed daily by eighty percent of the world’s population, making it
the most widely used stimulant drug. Caffeine has various benefits, side effects, and
withdrawal symptoms associated with its use, but there is a lack of research that studies
how much caffeine users know about these effects.
This research study assessed the use of caffeine for academic and professional
purposes and the knowledge about the benefits, side effects, and withdrawal symptoms of
caffeine among pre-PA students, PA students, and practicing PAs in Minnesota.
To do so, a paper copy of a survey was given to pre-PA students and didactic year
PA students Bethel University. An online copy was sent to clinical year PA students and
practicing PAs from Bethel University. An online copy of the survey was also sent to
pre-PA students, current PA students, and practicing PAs who had recently graduated
from St. Catherine University and Augsburg College.
Various demographic statistics were gathered. The statistics did show that
practicing PAs used caffeine for academic purposes significantly less than the three other
groups. PA students in their clinical year use caffeine significantly more for professional
purposes than both pre-PA students and PA students in their didactic year. Additionally,
practicing PAs used significantly more caffeine, generally, than PA students in their
didactic year. As far as caffeine knowledge, data collected revealed that PA students in
their clinical year had significantly more “very good” knowledge on the benefits of
caffeine than the three other groups. Results were limited due to sample size.
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Chapter 1: Introduction
Background
Eighty percent of the world’s population consumes caffeinated beverages daily,
making it the single most widely used stimulant drug. “Caffeine’s popularity is attributed
to its perceivable and acute benefits for physiological, psychomotor and cognitive
performance, as well as its beneficial effects on mood” (Einöther & Giesbrecht, 2013, p.
252). As a stimulant, caffeine is pharmacologically active through the antagonism of
adenosine (A1) receptors. This mechanism combats adenosine’s tendency to slow down
neural activity and promote wake-sleep cycles. Caffeine stimulates the release of
dopamine, which has shown to improve cognitive alertness and executive
functioning. Additionally, caffeine competes with adenosine at the A2 receptors to
enhance psychomotor activity and stimulate vasoconstriction (Einöther & Giesbrecht,
2013, p. 253).
Caffeine is a psychoactive substance. This means that its overuse and acute
decrease in ingestion may cause adverse effects. In a study conducted by Pandejpong,
Paisansudhi & Udompunthurak (2014) on caffeine use in Thai medical students,
addiction and dependence may occur with heavy use of caffeine and may cause
withdrawal symptoms, such as “headache, irritability, inability to concentrate, drowsiness
and insomnia,” peaking at 48 hours post-use. In said study, 13 percent of participants
developed caffeine dependency and 28 percent of those who used more than 400 mg per
day developed caffeine withdrawal symptoms (Pandejpong, Paisansudhi, &
Udompunthurak, 2014, p. 191). In Juliano & Griffith’s critical review of caffeine
withdrawal (2004), headaches were reported as the most common symptom in 77 percent
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of the studies that analyzed withdrawal symptoms. The study suggested that withdrawal
symptoms can last anywhere from two to nine days following discontinuation of
use. Another study on the health effects of caffeine suggests that chronic caffeine use
might cause restlessness, exacerbation of pre-existing anxiety or other psychiatric
symptoms, as well as tachycardia, and gastrointestinal disturbances. Unfortunately, there
is currently no reference value established for acceptable daily caffeine use, and
differences in caffeine metabolism make it difficult to quantify an upper toxicological
limit (Gasper & Ramos, 2016).
Because of caffeine’s widely accepted role in general arousal, students use it in
attempts to enhance cognitive abilities and remain awake for extended periods of time. A
study conducted by Lee et al. (2009) on medical students’ use of caffeine for academic
purposes mentioned that “the widespread use of caffeine may be due to the fact that its
habitual consumption has been significantly related to increased self-reported alertness,
improved performance of vigilance tasks and fewer lapses of attention, improved longterm memory and faster locomotor speed” (Lee et. al 2009, p. 322). However, caffeine
can only reliably improve cognitive performance when dosage intervals are spread at
least eight hours apart. If not used with caution, overuse can result in various adverse
effects and withdrawal symptoms. Lee’s study maintained, “the majority of participants
were using caffeine without sufficient knowledge of its benefits, side-effects and
withdrawal symptoms” (Lee et. al 2009, p. 326).
Although studied quite frequently, caffeine’s widespread effects on the body and
the complexity of factors that shape its use make it one of the most inadequately
understood drugs. Multiple studies have been conducted on the widespread physiological
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and psychological effects of caffeine, but much less time has been devoted to the study of
misconceptions about caffeine’s benefits, side effects, and withdrawal symptoms. This
study attempted to manipulate Lee’s 2009 study among pre-physician assistant (pre-PA)
students, physician assistant students, and physician assistants (PAs) in practice to
analyze the use of caffeine for academic or professional purposes and overall knowledge
of its properties.
Problem Statement
There is a general lack of information regarding the benefits, side effects, and
withdrawal symptoms associated with acute and chronic caffeine ingestion. Many
studies have focused on the physiological components of caffeine (Einöther &
Giesbrecht, 2013, Pandejpong, Paisansudhi, & Udompunthurak, 2014), but few studies
approach caffeine use among higher learners from the lenses of purpose of use and
misconceptions. There is almost no research conducted on caffeine use and knowledge
among pre-PA students, PA students, and practicing PAs. Thus, research must be
conducted on the role of caffeine use in the physician assistant field and misconceptions
about its benefits, adverse side effects, and withdrawal symptoms associated with its use.
Purpose
The main purpose of this study was to assess the use of caffeine for academic and
professional purposes, as well as the knowledge about the benefits, side effects, and
withdrawal symptoms of caffeine among pre-PA students, PA students, and practicing
PAs in Minnesota. Additional purposes included determining the most commonly used
caffeine products, how frequently caffeine is used for academic and professional
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purposes, and the differences in frequency of caffeine usage among prospective PAs and
practicing PAs.
Research Questions
Through this study the following questions were addressed:
1. What is the prevalence of caffeine use for academic and professional purposes in
pre-PA students, PA students, and practicing PAs in Minnesota?
2. What, if any, differences are there in the frequency of caffeine use for academic
and professional purposes between pre-PA students, PA students, and practicing
PAs in Minnesota?
3. What is the level of knowledge among these individuals on the benefits, side
effects, and withdrawal symptoms of caffeine?
Significance of the Study
With caffeine being one of the most commonly used drugs in the world, it is
important for users to have sufficient knowledge of its pharmacological features. The
findings of this study provide information about the prevalence of caffeine use for
academic and professional purposes and addresses whether there is a need to educate
individuals about the physical, cognitive, and psychological benefits and side effects of
caffeine. Based on the results of the study and the determined need for caffeine
education, information can be disseminated on the benefits, side effects, and withdrawal
symptoms of caffeine, providing individuals with sufficient and accurate information.
Limitations of the Study
While the research was meticulously organized in order to reach its aims, there
were several unavoidable limitations. Due to the inability of distributing a paper copy of
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the survey in-person to all subjects, there was a paper versus computer administration
limitation. An online version of the survey was distributed to all groups with the
exception of Bethel pre-PA students and Bethel PA students in their didactic year, who
were given a paper version. Regardless of whether the survey was given online or inperson there was no control over the response rate from all subjects. However, an online
version of the survey could result in a lower response rate. The researchers did
everything in their power to reduce coercion for the in-person survey. It had to be
assumed that all subjects honestly responded to the survey questions without guessing or
cheating. The main delimitation of this study was that subjects were limited to pre-PA
students, current PA students, and practicing PAs in the state of Minnesota. In addition,
practicing PAs were limited to those who graduated from one of the following
institutions: Augsburg College, Bethel University, or St. Catherine University.
Definition of Terms
Pre-Physician Assistant Student: Eligible students are members of a prephysician assistant club at Bethel University, St. Catherine University, Augsburg College,
the University of Minnesota Twin Cities, the University of Minnesota Duluth, or the
College of St. Scholastica. In addition, students who have been accepted into the PA
program at Bethel University, St. Catherine University, or Augsburg College, but have
not yet started classes are eligible as pre-PA students.
Physician Assistant Student: PA students enrolled in an accredited or
provisionally accredited PA program in Minnesota are eligible.
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Practicing Physician Assistants: A certified practicing physician assistant that has
graduated within the last five years from Bethel University, St. Catherine University, or
Augsburg College.
Caffeine: A central nervous system stimulant of the methylxanthine class of
drugs that is found in coffee, tea, cola nuts, mate and guarana (Weinberg & Bealer,
2001).
Caffeine Withdrawal: Physical and psychological symptoms occurring from
acute lowering of caffeine ingestion in a mild to moderate user, usually occurring within
12 -24 hours of discontinuing use.
Caffeine Use for Academic Purposes: The use of caffeine in order to lengthen
study time, stay awake during class, improve academic performance, and/or increase
efficiency on assignments and studying.
Caffeine Use for Professional Purposes: The use of caffeine in order to stay
awake while working with patients and completing paperwork, improve work
performance, and/or increase productivity on work-related duties.
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Chapter 2: Literature Review
Introduction
Caffeine is a psychoactive organic compound present in coffee, tea, cola, and
cocoa that easily permeates cell membranes and the blood brain barrier causing various
effects in the body and the central nervous system (Weinberg & Bealer, 2001). It is
consumed for pleasure of taste or to promote wakefulness and enhance cognition and
focus (Weinberg & Bealer, 2001). While beneficial in many ways, caffeine has side
effects and the potential to produce withdrawal symptoms. This literature review outlines
the current research on the common benefits, side effects, and withdrawal symptoms of
caffeine, as well as misconceptions in these areas.
Use of Caffeine
Research has shown that caffeine use has certain patterns. Lack of specific
research in caffeine use has lead to broad generalizations that may not necessarily be
reflective of the population as a whole. Caffeine use has shown to increase with age,
stabilizing around middle age and decreasing slightly with old age (Weinberg & Bealer,
2001). There appears to be no significant difference in caffeine use between genders, but
as women tend to weigh less than men, they will likely be exposed to higher levels of
caffeine and may experience stronger effects (Weinberg & Bealer, 2001). Today, more
than 80 percent of the American population consumes caffeine, with an average intake of
around 200 mg daily (Mitchell, Knight, Hockenberry, Teplansky, & Hartman, 2014;
Weinberg & Bealer, 2001).
A study by Astrid Nehlig (1999) began to outline some of the dietary sources of
caffeine, including tea, coffee, cocoa beverages, candy bars, and soft drinks. The highest
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use of caffeine was found in Sweden and Finland, where 80-100% of caffeine intake
comes from coffee (Nehlig, 1999). The United Kingdom had a level of intake similar to
some of the Scandinavian countries, but 70 percent of caffeine intake in the UK comes
from tea (Nehlig, 1999). This study mentioned that caffeine is consumed by children via
soft drinks, chocolate foods, beverages, and tea (Nehlig, 1999). In 2005, Frary, Johnson,
and Wang presented a study on caffeine intake in a representative population of the
United States. The study suggested that there was an increased percentage of Americans,
of all ages, who consume caffeine. The study also mentioned a small shift in sources of
caffeine with a higher prevalence of soft-drink consumption in relation to tea. Coffee
remains the primary source of caffeine in individuals two years and older (Frary,
Johnson, & Wang, 2005).
With the addition of various other caffeinated beverages and the prevalence of
energy drinks among youth, a population-based study of caffeine intake was necessary to
re-evaluate America’s overall use of caffeine. A survey conducted by Mitchell et al.
(2014) affirmed the assumption that caffeine is consumed by over 80% of the United
States population, echoing various past findings on the use of caffeine (Barone &
Roberts, 1996; Frary, Johnson, & Wang, 2005; Knight, C., Knight, I., Mitchell, & Zepp,
2004; Mitchell et. al, 2014). One notable finding in Mitchell’s 2014 survey was that the
most common sources of caffeine were carbonated soft drinks, coffee, and tea, which
were consumed by over half of the population of caffeine consumers. A surprisingly low
number of consumers reported use of energy drinks and energy shots (Mitchell et al.,
2014). According to the survey, only 4.3% of caffeine consumers reported energy drink
use (Mitchell et al., 2014). Even among the highest population of energy drink
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consumer, teenagers and young adults, only 5-7 % of their caffeine intake came from
energy drinks (Mitchell et al., 2014). In addition, Mitchell et al. (2014) noted that the
highest use of caffeine was in adults aged 50-64. While consuming slightly less in
volume, nearly 100% of individuals over 65 consume caffeine. The study’s final
conclusion was that newer caffeinated beverages, including energy drinks, energy shots,
and chocolate milk contribute little to the overall increase in caffeine among various age
groups (Mitchell et al., 2014).
While most of the current research on caffeine use provides general information
on the population, research regarding caffeine intake among college-aged or graduate
students tends to focus on sleep deprivation or the combination of caffeine and alcohol.
Much of the research discusses why caffeine is consumed, rather than who is consuming
it. For various reasons, caffeine is highly consumed and, if consumed in moderation,
studies below will show that it can be quite beneficial for the consumer’s overall health.
Benefits of Caffeine
Caffeine may be utilized for its beneficial effects. These benefits include increased
alertness, improved vigilance, increased ability to concentrate, better long-term memory,
increased speed of neurological activity, and reaction time. These are all benefits that
could be resulting in the widespread use of caffeine (Christopher, Sutherland, & Smith,
2005; Hameleers et al., 2000). Researchers have looked into a variety of benefits
associated with caffeine use; this literature review will only focus on the five benefits that
are incorporated into this study. These benefits include increased vigilance, increased
long-term memory, prevention of Alzheimer’s disease, prevention of Parkinson’s disease,
and prevention of Type II Diabetes Mellitus.
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The ability of caffeine to block the inhibitory action of adenosine allows it to
increase the activity of the central nervous system (Smith, 2002). While this general
mechanism of action is used to explain how caffeine can impact vigilance and long-term
memory, the underlying mechanisms are still unidentified and are being researched
today. Inconsistencies are found in the literature addressing caffeine’s effects on
vigilance and long-term memory. These inconsistencies could be explained by noting the
differences in methodology, the time at which the study was performed, and whether
confounding factors were being controlled (Nawrot, Hugenholtz, Feeley, Eastwood,
Jordan, & Rostein, 2003).
In 1987, Lieberman, Wurtman, Emde, Roberts, and Coviella performed a study in
which participants were administered caffeine dosages ranging from 32 mg to 256 mg
and then given eight different performance tests, three of which tested vigilance. Results
from this study showed that regardless of caffeine dosage all participants had significant
improvement in auditory and visual vigilance, which was based on the modified
Wilkinson vigilance test (Lieberman et al., 1987). The study found improvements in the
four-choice reaction time task, in comparison to the placebo group (Lieberman et al.,
1987). Frewer and Lader (1991), Mitchell and Redman (1992), and Fine et al. (1994)
conducted additional studies that confirmed caffeine’s positive effects on psychomotor
speed and vigilance. Another study by Hameleers et al. (2000) showed a similar increase
in vigilance, which was tested via a Visual Verbal Learning Test, Motor Choice Reaction
Test, Letter-Digit Substitution Test, Fluency Test, Concept Shifting Test, and Stroop
Color – Word Test, all of which differed from Lieberman’s tests. Not only did
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participants have an increased response rate, but the study found a direct relationship
between the rate of response and the amount of caffeine used (Hameleers et al., 2000).
Heatherley, Hayward, Seers, and Rogers (2005) realized research was lacking on
the effects of caffeine following periods of abstinence. This guided their research team to
conduct a study to determine the effect of caffeine on several measures, including
cognitive performance following 4-8 hour periods of caffeine abstinence. The study
concluded that cognitive performance could only be reliably improved if the consumer
abstains from caffeine for eight hours prior to additional doses (Heatherley et al.,
2005). Overall, the literature implies that caffeine use results in improved performance
on vigilance and simple tasks requiring continual response; while these effects are most
clearly seen when there is reduced alertness, evidence shows benefits occurring when an
individual does not have reduced alertness (Smith, 2002).
Similar to the effects of caffeine on vigilance, some incongruity exists in regards
to whether caffeine has an impact on an individual’s memory. Past studies have shown
contradicting results, in which some researchers found acute ingestion of caffeine to
improve memory functioning (Terry and Phifer, 1986), while others found it to have no
effect (Foreman, Barraclough, Moore, Mehta, & Madon, 1989; Mitchell and Redman,
1992). In Wing Hong Loke’s (1988) study, “Effects of Caffeine on Mood and Memory,”
he tested participants’ delayed recall performance by giving them three lists of words and
then testing their ability to remember those words 70 minutes following caffeine
use. Loke (1988) did not inform the participants about the delayed recall test prior to
administration. His results revealed habitual caffeine users consuming moderate-to-high
amounts (387.5-927.5 mg/week) were capable of recalling more words than low amount
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users (less than 387.5 mg/week) (Loke, 1988). These results were backed by the results
of Jarvis’ 1993 study, in which four tests all resulted in a direct relationship between
higher habitual caffeine use and enhanced memory performance and reaction time. A
more recent study conducted by Hameleers et al. (2000) found that higher habitual
caffeine use had a positive association with improved long-term memory. Again, no
significant association was found between caffeine use and improved short-term
memory. From the studies investigating this relationship, a person could imply that
habitual caffeine use is linked to improved storage or recovery from one’s long-term
memory. Not only does caffeine have an effect on long-term memory, but it has an
impact on one’s risk of Alzheimer’s disease.
Alzheimer’s disease (AD) is a neurodegenerative disease that results from
“progressive cognitive impairment and elevated levels of β-amyloid (Aβ) protein”
(Arendash et al., 2006, p. 941). Researchers suggest that caffeine use may reduce the risk
of AD and may be useful as a therapeutic agent by helping slow the progression of
cognitive decline. Caffeine reduces Presenilin 1 and β-secretase, which subsequently
results in the reduction of Aβ production (Arendash et al., 2006). Arendash et al. (2006)
conducted a study to prove that long-term caffeine use may protect mice against
cognitive impairment and may prevent or delay AD onset. Mice were administered the
human equivalent of 500 mg of caffeine (1.5 mg), and the study found that there was a
significant difference in cognitive task performance between the mice given caffeine and
those from whom it was withheld (Arendash et al., 2006). In addition to these findings,
the researchers also found that a 32-37% reduction in the hippocampal levels of Aβ was
seen in caffeine treated mice in comparison to untreated mice (Arendash et al., 2006).
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Arendash et al. (2009) continued researching this topic to determine if caffeine
could have beneficial effects in aged mice already experiencing cognitive
impairment. The study concluded that caffeine-treated aged mice had a 40% reduction of
Aβ production in the hippocampus and also recovered a level of working memory
comparable to that of aged mice not experiencing cognitive impairments (Arendash et al.,
2009). Additionally, the level of working memory restored was greater than that of
untreated, cognitively impaired aged mice (Arendash et al., 2009). Arendash and Cao
(2010) effectively demonstrated that no cognitive benefits were provided by long-term
administration of theophylline, a xanthine derivative similar to caffeine, and that
decaffeinated coffee has no effect on the levels of Aβ, indicating that caffeine, rather than
its derivatives, had effects on cognitive impairment. The literature suggests that
moderate caffeine intake has the potential to provide protection against and therapy for
AD.
Caffeine has been found to reduce the risk of developing Parkinson’s disease
(PD). Parkinson’s disease is a chronic, progressive degenerative disease involving the
dysfunction and death of dopamine producing neurons. Dopamine is involved in
movement control and coordination (National Institute of Neurological Disorders and
Stroke [NINDS], 2015). As patients with PD progress, they are unable to control
movements due to decreased dopamine production in the brain (NINDS,
2015). Researchers suggest that consuming caffeine could decrease the risk of PD, due to
caffeine’s antagonistic action (Schwarzschild, Chen, & Ascherio, 2002). A study
conducted by Ross et al. (2000) consisting of over 8,000 Japanese-American men
between 45-68 years old, found that male non-coffee drinkers were five times more likely
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to develop PD over the subsequent 24-30 years than those who consumed at least 28
ounces daily.
An alternative study found that men who consume more than four cups of coffee
daily have half the risk of developing PD over the next 10 years than men who did not
drink coffee (Ascherio, Chen, Schwarzschild, Zhang, Colditz, & Speizer,
2003). Ascherio, Zhang, Hernán, Kawachi, Colditz, and Speizer (2001) found that the
lowest risk for developing PD in women was found in those drinking 1-3 cups of coffee
daily. Ascherio et al. (2001) suggests that estrogen accounts for the overall lower risk of
PD in women in comparison to men, but a difference is also shown in the caffeine-PD
risk relationship between genders. According to a meta-analysis conducted by Hernán,
Takkouche, Caamaño-Isorna, and Gestal-Otero (2002), the overall risk of developing PD
is 30% lower for those consuming coffee compared to non-coffee drinkers. The research
concluded “every additional cup of coffee per day is associated with a risk reduction of
10%, although the magnitude of this reduction may differ by gender” (Hernán et al.,
2002, p. 281). While there is a difference in the amount of coffee that needs to be
consumed between men and women to decrease PD risk, one can still deduce from the
research that the two are inversely related. With that information, more knowledge needs
be acquired on the relationship prior to recommending increased caffeine intake as a
therapeutic means of preventing PD (Higdon & Frei, 2006).
Lastly, caffeine use has a positive effect on the risk for Type II Diabetes Mellitus
(DM). Type II DM is characterized by an increase in blood glucose levels due to insulin
resistance (American Diabetes Association, 2009). According to Higdon and Frei (2006),
several possible mechanisms exist by which coffee decreases the risk for Type II
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DM. These mechanisms include the inhibitory effect of chlorogenic acid (a component
in coffee) on the glucose-6-phosphatase system and intestinal glucose absorption, the
increase in magnesium absorption, as well as an increase in energy expenditure and
weight loss (Higdon & Frei, 2006). In a 2002 prospective study, van Dam and Fenskens
concluded that individuals drinking a minimum of seven cups of coffee a day had a 50%
lower risk of developing Type II DM in comparison to the risk of individuals drinking no
more than two cups. Similarly, the study of Tuomilehto, Hu, Bidel, Lindström, and
Jousilahti (2004) made up of over 14,000 participants and spanning roughly 12 years
found that men who consumed 10 or more cups of coffee daily had a 55 % less risk of
developing type II DM than that of men who had consumed no more than two cups
daily. Additionally, women who consumed a minimum of 10 cups of coffee daily had a
risk that was 80% less than that of women who had consumed two cups or less
(Tuomilehto et al., 2004). A study piloted by Rosengren, Dotevall, Wilhelmsen, Thelle,
and Johansson (2004) enhanced the finding of Tuomilehto et al. (2004) by studying
Swedish women over 18 years and coming to the conclusion that women who consumed
no more than two cups of coffee per day had a 44% greater risk of developing Type II
DM than women who drank a minimum of three cups per day. In 2005, van Dam and Hu
performed a systematic review of nine studies, including over 193,000 men and
women. They examined the coffee relationship to Type II DM risk relationship. The
review concluded that individuals who had a daily intake of at least six cups of coffee per
day and individuals who had a daily intake between 4-6 cups had a 35% lower risk and a
28% lower risk, respectively, than those who drank no more than two cups daily (van
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Dam & Hu, 2005). Overall, the literature has revealed a significant inverse association
between coffee intake and Type II DM.
Aside from the benefits discussed above, the additional benefits of caffeine use
are not noted because the survey used in the current study does not include them. The
beneficial effects caffeine has on vigilance, long-term memory, and the lower risk of AD,
PD, and Type II DM has been reinforced by the existing literature.
Side Effects of Caffeine
When consuming caffeine, individuals do not often think about the side effects
associated with its use. Studies have been conducted on the cardiovascular health effects
of chronic and acute caffeine use (Lee et al., 2009; Pincomb et al., 1985). As a stimulant,
caffeine works directly on myocardial tissue, increasing cardiac output, force of
contractility, and heart rate (Lee et al., 2009). A double-blind, placebo-controlled study
by Pincomb et al. (1985) found that “caffeine increased ventricular ejection time and
stroke work, while decreasing systolic ejection acceleration” (Pincomb et al., 1985, p.
121). This led to an increased afterload and the enhancement of vascular resistance.
A study by Doerner et al. (2015) on caffeine energy drinks containing taurine, an
amino acid that supports neurologic development, found a subtle but significant increase
in left ventricular contractility one hour after use in healthy volunteers. An increase in
left ventricular contractility inadvertently causes an increase in heart rate and cardiac
output (Doerner et al., 2015). The study mentioned that while caffeine is known to
increase blood pressure and stimulate diuresis, the inotropic effect of caffeine is still a
matter of controversy (Doerner et al., 2015). Additional studies have affirmed that while
caffeine increases heart rate, caffeine use has no significant association with arrhythmias
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and moderate use of caffeine does not appear to negatively affect cardiovascular health
(Gasper & Ramos, 2016; Tofalo, Renda, De Caterina, & Suzzi, 2016).
More extensive research has been done on the relationship between caffeine and
hypertension. A study by Shepherd, Absi, Whitsett, Passet, and Lovallo (2000) on
additive pressor effects of caffeine and stress in medical students, found that caffeine
increases blood pressure and cortisol responses during times of increased mental
stress. However, Tofalo et al.’s (2016) review of the health effects of coffee reflected a
meta analysis of cohort and randomized control trials that long-term coffee use has no
increased risk in hypertensive consumers. Despite caffeine’s acute tendency to raise
heart rate and blood pressure, chronic moderate caffeine use does not pose any major
threat to cardiovascular health (Tofalo et al., 2016).
As previously discussed, caffeine use will result in an increased heart rate and
force of contraction. These effects coincide with the effect caffeine has on respiratory
rate. There are several mechanisms that have been suggested which include “an increase
in pulmonary blood flow, an increased supply of air to the lungs … an increase in
sensitivity of the medullary respiratory center to carbon dioxide, … and an increase in
cardiac output” (Arnaud, 2005, p. 251). According to Benowitz (1990), the sensitization
of the medullary center to carbon dioxide is likely what causes the increase in respiratory
rate. D’Urzo (1990), who had found a 20% increase in respiratory rate due to coffee
intake, supported the above mechanism. Caffeine has been used to treat asthma in
children due to its function as a potent bronchodilator without adverse central nervous
system side effects, but with other potential effects on growth and development, the use
of caffeine in young children is still controversial (Weinberg & Bealer, 2001).
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An additional side effect of caffeine use is sleep disturbances. Caffeine is
beneficial in allaying fatigue and drowsiness, but caffeine can induce disruptions,
resulting in a lower quality of sleep (Landolt, 2015). Brezinova’s 1974 study
investigated caffeine's effect on sleep. It discovered that participants who consumed
caffeine 15 minutes prior to sleep had an average of a two hour reduction in mean total
sleep time. Caffeine caused a 66-minute increase in the mean sleep latency and increased
number of awakenings throughout the night. The study observed a change in sleep
patterns in which there was a decrease in the amount of stage three sleep during the first
three hours and an increase in the amount of stage two sleep (Brezinova, 1974). The
effects of ingesting caffeine 30-60 minutes prior to bedtime generally leads to an
increased latency in sleep onset, shorter duration in sleep, and more disturbed sleep
(Nehlig, Daval, & Debry, 1992). Paterson, Wilson, Nutt, Hutson, and Ivarsson (2007)
found a 155% increase in sleep onset in volunteers who were administered 150 mg of
caffeine prior to bedtime in comparison to the placebo group. Puckeridge, Fulcher,
Phillips, and Robinson (2011) sought to use a quantitative model to further investigate the
effect caffeine has on sleep loss and sleep onset. The study found that caffeine causes an
increase in sleep loss and sleep onset. Moreover, Puckeridge et al. (2011) disclosed that
large doses of caffeine and doses taken right before bedtime had the greatest disturbance
effects. Small amounts of caffeine use (no more than one cup of coffee) have no
significant impact on sleep loss, but the use of large doses (about 800 mg) can result in a
sleep deficit of an hour (Puckeridge et al., 2011). In addition to Puckeridge et al., Hans
Peter Landolt (2015) explained that the high occurrence of sleep issues following caffeine
use may be linked to the interference caffeine has on the circadian clock.
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In conclusion, the literature suggests that caffeine use is associated with various
cardiovascular, respiratory, and sleep-related side effects that can be detrimental to health
if not properly managed.
Caffeine Withdrawal Symptoms
Withdrawal of nervous system stimulation can result in the production of many
temporary psychiatric changes including difficulty concentrating, depressed mood,
headache, fatigue, drowsiness, irritability, decreased alertness, nausea, vomiting, and
others (Pandejpong, Paisansudi, & Udompunthurak, 2014). Many of these withdrawal
symptoms arise 12-24 hours after an acute abstinence of caffeine and may reach peak
intensity anywhere between 20-51 hours following abstinence (Juliano and Griffiths,
2004). For the purpose of this literature review and our study, the focus will be on five
withdrawal effects — headaches, fatigue, drowsiness, decreased alertness, and mood
disturbances.
Headaches are reported as the most common symptom of caffeine withdrawal
(Juliano and Griffiths, 2004). Silverman, Evans, Strain, and Griffiths (1992) performed a
double blind study on the cessation of caffeine use. Each participant filled out a series of
questionnaires at baseline, was given caffeine capsules or placebo twice a day over two,
two-day periods, and then reassessed. After reassessment, many of the items on the
withdrawal questionnaire were statistically significant. Report of a headache was the
most significant withdrawal effect with 52% of participants indicating a moderate to
severe headache during caffeine withdrawal. Only 2% indicated any headache during at
baseline, and 6% of participants indicated a headache during the periods of caffeine
administration (Silverman et. al, 1992). Similarly, Rubin and Smith (1999) developed a
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study that focused specifically on headaches and caffeine withdrawal. The study
revealed that there was no significant difference in reports of a headache at baseline
compared to the number of headaches during caffeine use, but a significant increase was
shown in headaches reported during the periods of decaffeinated coffee use. Evans and
Griffiths (1999) studied how different increments of substituted doses of caffeine
impacted the severity of a headache when compared to a baseline level. They found that
not only was the onset of a headache common, but the severity and incidence of
headaches also increased as the substituted dose of caffeine decreased (Evans and
Griffiths, 1999).
van Dusseldorp and Katan (1990) studied the effects of long-term cessation of
caffeine. In a double-blind experiment, two groups were matched for sex, age, and
overall general health. All participants were regular coffee users consuming 4-6 cups per
day. The first group was given five cups of coffee each day (84 mg caffeine/cup), for six
weeks, while the second group was given five cups of decaffeinated coffee each day
(3mg caffeine/cup) for six weeks (van Dusseldorp and Katan, 1990). At the end of six
weeks, each group was switched to either caffeinated or decaffeinated coffee for another
six weeks. About 42% of participants complained of an increase in headaches in the first
week of taking decaffeinated coffee, as compared to the other 11 weeks of the study. On
average the headaches started within 1-2 days and lasted from 1-6 days (van Dusseldorp
and Katan, 1990). The results of these studies support headaches as a common
occurrence in those who abstain from caffeine in acute and long-term settings. The
severity of a headache may have some correlation to the level of caffeine tolerance prior
to withdrawal.
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Drowsiness and fatigue are also common in those who experience caffeine
withdrawal. Rogers, Heatherly, Mullings, and Smith (2012) looked at the effects of
caffeine withdrawal and the effects of caffeine re-administration. Rogers et. al (2012)
found that caffeine withdrawal has a significant effect on increasing levels of drowsiness
in people who had medium-high levels of caffeine use prior to withdrawal of the
caffeine. Caffeine withdrawal had little effect on drowsiness in those who were moderate
or high-dose consumers of the drug, which was likely due to their lower levels of
tolerance to caffeine (Rogers et. al, 2012).
In a double blind, placebo controlled, crossover study, Phillips-Bute and Lane
(1997) studied how short-term withdrawal from caffeine may produce various withdrawal
symptoms, including fatigue. Short-term withdrawal was defined as abstaining four
hours beyond a normal intake of coffee in the morning. Then, they were then given a
series of questionnaires asking about their current mood and withdrawal
symptoms. Participants were asked to perform a simple task of reaction time and
cognitive functioning. On the mood questionnaire, participants indicated a significant
increase in fatigue. Fatigue was one of only two categories that were statistically
significant, with the other category being a decrease in vigilance/activity. On the
withdrawal symptom questionnaire, increased sleepiness and yawning were the only two
categories out of 17 total that had a significant change (Phillips-Bute and Lane,
1997). Juilano, Huntley, Harrell, and Westerman (2012) and Hughs et al. (1991) also
found a significant increase in fatigue after periods of caffeine abstinence.
The intake of caffeine has been found to enhance alertness, the ability to achieve,
and sensitivity to incoming stimuli, mainly by its interactions with the central
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dopaminergic systems of the brain (Einöther and Giesbrecht, 2013). Withdrawal of
caffeine can elicit opposite effects of decrease in mental alertness, particularly in those
who are medium-high consumers of caffeine. No significant decrease was found in
alertness of those who do not consume caffeine or consume it in low doses (Rogers et al,
2012). Evans and Griffiths (1999) found that a decrease in mental alertness might be
correlated to the amount of caffeine that was consumed prior to withdrawal. In a 73-day
study, no evidence suggested a decrease in alertness when the maintenance dose of
caffeine was 100 mg prior to withdrawal. A significant decrease in mental alertness was
found when the maintenance dose of caffeine was 300mg and 600mg prior to
withdrawal. However, a study done by Phillips-Bute and Lane (1997) did not find this to
be true, since no significant effect on mental alertness was revealed in their study on
caffeine withdrawal symptoms. This contraindication found by Phillips-Bute and Lane
(1997) was likely due to different methodologies.
Withdrawal of caffeine has been shown to elicit an overall disturbance in mood
such as increased irritability, depressed feelings, and a decrease in social disposition, self
confidence, well being, and feelings of being content (Griffiths et al., 1990). Garrett and
Griffiths (1998) studied a similar effect through a “caffeine challenge.” During the first
phase of the experiment, participants were placed on a placebo two times a day, or
caffeine (300mg/70kg, twice daily) for twelve days, and then were switched in a second
phase to the opposite condition for another twelve days (Garrett and Griffiths,
1998). The first two days were used to gradually stabilize the doses in those who were
placed in the initial caffeine group, while the first three days were used to slowly stabilize
those who were placed in the initial placebo group in order to minimize caffeine
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withdrawal effects (Garrett and Griffiths, 1998). On the last two days of each phase,
participants were given either a placebo or caffeine, providing four conditions: caffeine
challenge after chronic caffeine administration, placebo challenge after chronic caffeine
administration, caffeine challenge after chronic placebo administration, and placebo
challenge after chronic placebo administration (Garrett and Griffiths, 1998). Through a
series of questionnaires, a disturbed, or depressed mood was found to be a significant
withdrawal effect during the placebo challenge after chronic caffeine administration. It
was noted that participants were willing to forfeit small sums of money ($2.14) to avoid
receiving this placebo challenge again (Garrett and Griffiths, 1998).
Misconceptions About Caffeine
Although much research has been done on how caffeine use and withdrawal affect
the body, there appear to be misconceptions within the general population on the actual
effects. Anderson, Juliano, and Schulkin (2009) studied how much knowledge
obstetricians and gynecologists had about caffeine and how these providers implemented
this knowledge into their practice. Over 85% of participants either overestimated or
underestimated the amount of caffeine in commonly used products such as espresso and
Diet Coke and only 58% of these providers discuss the use of caffeine with their patients
(Anderson, Juliano, and Schulkin, 2009).
Lee et al. (2009) studied misconceptions about caffeine in first, second, and third
year medical students in South Africa. Students were surveyed on the benefits, side
effects, and withdrawal symptoms of caffeine use. Although 93% of students were
regular caffeine consumers, the results showed that the majority of these medical students
did not have accurate knowledge of caffeine’s effects. Many students (26.7%)
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inaccurately identified “substitute for sleep” as a benefit for caffeine use. Hot flashes
(21.9%) and acne (18.3%) were mistaken as side effects, and 27% of students wrongly
identified aggression as a symptom of withdrawal (Lee et. al 2009).
A lack of further research on misconceptions regarding caffeine exists,
particularly among graduate students; yet, accurate knowledge on the benefits, side
effects, and withdrawal symptoms of caffeine is necessary as caffeine is the most widely
consumed drug in the world.
Summary
While an abundance of information can be found on the benefits, side effects, and
withdrawal symptoms of caffeine, a lack of research measures how much people know
about these effects. The current study looks at the use and misconceptions in prephysician assistant students, current physician assistant students, and practicing physician
assistants. This study attempts to expand the knowledge in this area as it identifies what
misconceptions people may have about caffeine and by doing so, expand on these
misunderstandings already acknowledged by Lee et al. (2009).
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Chapter 3: Methodology
Introduction
The main purpose of this study was to assess the use of caffeine for academic and
professional purposes, as well as the knowledge about the benefits, side effects, and
withdrawal symptoms of caffeine among pre-PA students, PA students, and practicing
PAs in Minnesota. Additional purposes included determining the most commonly used
caffeine products, how frequently caffeine is used for academic and professional
purposes, and the differences in frequency of caffeine usage among prospective PAs and
practicing PAs. The questions addressed as part of this research were:
1. What is the prevalence of caffeine use for academic and professional purposes in
pre-PA students, PA students, and practicing PAs in Minnesota?
2. What, if any, differences are there in the frequency of caffeine use for academic
and professional purposes between pre-PA students, PA students, and practicing
PAs in Minnesota?
3. What is the level of knowledge among these individuals on the benefits, side
effects, and withdrawal symptoms of caffeine?
This chapter contains information on the study population, materials and
instrumentation, study design, procedures, statistical analysis, validity and reliability,
limitations, and delimitations of the study.
Study Population
The participants of this study were pre-PA students, current PA students, and
practicing PAs in the state of Minnesota. Eligible pre-PA students were members of a
pre-PA club at Bethel University, St. Catherine University, Augsburg College, the
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University of Minnesota Twin Cities, the University of Minnesota Duluth, and the
College of St. Scholastica. In addition, students who had been accepted into the PA
program at Bethel University, St. Catherine University, or Augsburg College, but had not
yet started classes were considered pre-PA students. Current PA students were restricted
to those enrolled in the Augsburg College, Bethel University, or St. Catherine University
PA programs. The practicing PAs were graduates within the last five years from the PA
program at Augsburg College, Bethel University, or St. Catherine University. A letter of
intent was sent to Augsburg College, Bethel University, and St. Catherine University in
order to receive permission to survey their students (see appendix A, B, and C). The
estimated number of participants was 140 pre-PA students, 180 PA students (90 didactic
year student and 90 clinical year students), and 100 practicing PAs.
Materials and Instrumentations
This study utilized a survey tool originally developed in a previous study by Lee
et al. (2009) (see Appendix D). Although Lee et al.’s study was performed on medical
students; this survey was most applicable to measure the same qualities among pre-PA
students, PA students, and practicing PAs. Permission to use the survey and make any
necessary changes was obtained from Dr. Carol Larson, one of the authors and
correspondent of the study (see Appendix E). Small changes were made to manipulate
the survey, applying it to pre-PA students, PA students, and practicing PAs. Changes
were made to demographic questions to reflect the study sample. The word impotency
(listed under side effects and withdrawal symptoms) was replaced by erectile dysfunction
for better clarification. One side effect (increases gastric secretion was changed to
increases sleep disturbances) and one withdrawal symptom (constipation was changed to
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increases mood disturbance) was changed to reflect current literature, but the rest of the
survey questions regarding knowledge of caffeine’s benefits, side effects, and withdrawal
symptoms remained unchanged (see Appendix F).
A paper copy of the survey was distributed in person to gather data from pre-PA
students and didactic year PA students from Bethel University. An electronic survey
software, Qualtrics®, was utilized to gather data from the remaining pre-PA students,
didactic year PA students, clinical year PA students, and practicing PAs. Both surveys
were exactly the same and were used to collect the following information:
1. Demographic data
2. Data regarding the use of caffeine
3. Data conveying whether or not the individual has knowledge on the benefits of
caffeine
4. Data conveying whether or not the individual has knowledge on the side
effects of caffeine
5. Data conveying whether or not the individual has knowledge on the
withdrawal symptoms of caffeine
The electronic survey link was sent to a PA program faculty member of each
school to be distributed to the proposed participants. These faculty members served only
as distributors of the survey and did not participate in the study, unless they met the
definition of a practicing PA.
Study Design
A quantitative study was conducted in order to assess use of caffeine and
knowledge of its benefits, side effects, and withdrawal symptoms among pre-PA
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students, current PA students, and practicing PAs. The study can be defined as a
descriptive, survey-based study reflective of this population.
Procedure
A paper copy of the survey was handed out in person to Bethel pre- PA students
at a pre-PA meeting and current Bethel didactic year PA students during class. The same
survey was emailed (see Appendix G) to remaining pre-PA students, didactic year PA
students, clinical year PA students, and practicing PAs. Participants were given a letter
of informed consent, which acknowledged that submission of their survey indicates
release of submitted data for professional use (see Appendix H). Participants of the study
were not offered compensation for participating in this study, thus reducing the
possibility of coercion.
Prior to starting the survey, the following statement was read to the participants
taking the survey in person or displayed online for those taking the electronic version:
“This study is being conducted by first year students in Bethel University’s Physician
Assistant program. The following survey will assess the participant’s knowledge on the
benefits, side effects, and withdrawal symptoms of caffeine. It should take no longer
than 5 to 10 minutes to complete. You will not be asked about any personal information
and only the researchers and their committee will have access to submitted data. You are
NOT required participate in this survey. Should you choose to participate, your signature
on the letter of informed consent will serve as an acknowledgement that submission of
your survey indicates release of data for professional use.”
In order to obtain an optimal response rate from the online surveys, participants
were given a four-week period to complete the survey. A reminder email (see Appendix
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I) with the survey link was also sent to the PA program faculty member two weeks after
the survey opened to remind individuals to complete the survey.
After the electronic survey expired and all paper copies were compiled, the data
was analyzed and discussed. Only the researchers and the research committee examined
data collected from the surveys. Confidentiality was assured, as participants were not
asked about personal information. Informed consent and Bethel IRB approval (see
appendix J) was obtained to ensure participants’ rights were be upheld. Data from the
surveys completed electronically were kept secure on Qualtrics® under their "Privacy
Policy.” Data collected from the paper-copy surveys will be stored in a secure cabinet in
the Physician Assistant program at Bethel University for five years.
Statistical Analysis
The prevalence of caffeine use was divided into four main groups for analysis: no
caffeine use, caffeine use for academic purposes, caffeine use for professional purposes,
and caffeine use for other purposes. The total number of respondents who answered
“yes” to caffeine use on the survey were asked to reply to reasons for use of
caffeine. These answers were totaled by group (Pre PA students, PA students in their
didactic year, PA students in their clinical year, and practicing PAs) and reported as a
percentage of the total number in each group that responded.
Participants indicated how frequently they used caffeine for academic and/or
professional purposes. Data was analyzed for frequency of caffeine use for academic or
professional purposes. This data was analyzed using a One-Way ANOVA. Due to
statistical significance, a Tukey Post-Hoc test was performed as well to determine which
groups were significantly different
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During data analysis, the section regarding knowledge about caffeine was scored
on a scale of 0-5. The participants were given two scores for each of the last three
questions. The first score pertained to the number of correct options selected and the
second score pertained to the number of incorrect options selected. For each correct
response the participant received 1 point (maximum of 5 points) toward their first
score. For each incorrect response the participant received 1 point (maximum of 5
points) toward their second score. The participants neither gained nor lost any points if a
question went unanswered. Participants’ scores were then calculated and
categorized. The correct response scores were categorized as follows: 0 = without
knowledge; 1 = very little knowledge; 2 = little knowledge; 3 = moderate knowledge; 4 =
good knowledge; and 5 = very good knowledge. The incorrect response scores were
categorized as follows: 0 = very good knowledge; 1 = good knowledge; 2 = moderate
knowledge; 3 = little knowledge; 4 = very little knowledge; and 5 = without knowledge
(See Appendix K for survey grading rubric).
Identical but separate analyses were done for each of the six knowledge
categories: benefits correct, benefits incorrect, side effects correct, side effects incorrect,
withdrawal symptoms correct and withdrawal symptoms incorrect. The coding for the
six categories was applied to all four demographic groups: pre-PA students, PA students
in their didactic year, PA students in their clinical year, and practicing PAs. For
clarification, “benefits correct” and “pre PA students “ is used as an example of coding
for an analysis. If there were 19 out of 71 pre-PA students who scored a 0 (without
knowledge) on the benefits of caffeine, SPSS was coded with 19 “1s” and 52 “0s” for the
remainder of those who did not fall into the category of without knowledge. If there were
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42 out of 71 pre-PA students who scored a 1 (very little knowledge), SPSS was coded
with 42 “1s” and 29 “0s.” This continued with scores 2-5 and applied to the four
statistical groups.
Per the statistical analysis conducted by Lee et al. (2009), a Kruskall-Wallis test
was used to analyze numerical data about participants’ knowledge of caffeine (correct
and incorrect) on each of the six categories: benefits correct, benefits incorrect, sideeffects correct, side-effects incorrect, withdrawal symptoms correct, and withdrawal
symptoms incorrect. For statistical significance, at least 40 participants from each group
was necessary.
Validity and Reliability
The survey used in this study was obtained from a previous study (Lee et al.,
2009) and was used with permission. The survey used in Lee et al.’s study was
appropriately approved for validity through the use of a pilot study on twenty
physiotherapy students from the same school. Results of Lee et al.’s study demonstrated
that the survey questions provided accurate information about participants’ knowledge of
caffeine’s benefits, side effects, and withdrawal symptoms among medical
students. Small changes were made with permission, to allow the study to represent a
population of pre-PA students, PA students and practicing PAs, rather than medical
students that were originally studied. The survey was given only to pre-PA students,
current PA students, and practicing PAs in Minnesota, and therefore, our results cannot
be applied nationally. This affected the study’s external validity.
To help ensure the reliability (specifically readability and understandability) of
this research, the survey was reviewed by three certified PAs who have been in practice
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for at least five years. These PAs served as an expert panel review before distribution of
the survey to the study’s participants. To confirm readability and understandability,
minor changes were made to the survey, per suggestions of the panel.
Limitations and Delimitations
The following is a delimitation the researchers believed was a potential weakness
in the study. Subjects were intentionally limited to pre-PA students, current PA students,
and practicing PAs in the state of Minnesota. In addition, practicing PAs were limited to
those who graduated within the last five years from one of the following institutions:
Augsburg College, Bethel University, or St. Catherine University. For convenience
sampling, researchers believed this gave the best sampling of the Minnesota PA
population as these schools were the only accredited programs in the state of Minnesota
at the time of this study.
The following are limitations the researchers believed to be potential weaknesses
in the study. First, regardless of whether the survey was given in an email or as a paper
copy in-person there was no control over the response rate from all subjects. An online
version of the survey could have resulted in a lower response rate due to the large
quantity of emails one receives in a day. It was possible that the email containing the
survey could be disregarded, lost, or sent to spam, and may affect the final analysis. The
goal was that all subjects would respond to the survey questions based on their own
knowledge levels without using outside resources during the survey. However, the
researchers had no control over the subjects’ use of these resources.
While the research was precisely planned, these limitations were
unavoidable. Several steps were taken in order to help avoid some of the limitations
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stated above. In order to increase response rate from the online surveys, an initial email
was sent requesting that individuals partake in the survey. Two weeks into the survey
period, a reminder email was sent. Each participant was informed that his or her
responses would be confidential and that honest responses would help provide more
accurate results.
Conclusion
The listed methodology provided a comprehensive process to conduct this
research project and assess the usage of caffeine for academic and professional purposes,
as well as the knowledge about the benefits, side effects, and withdrawal symptoms of
caffeine among pre-PA students, PA students, and practicing PAs in Minnesota. The
methodology also determined the most commonly used caffeine products, how frequently
caffeine is used for academic and professional purposes, and the differences in frequency
of caffeine usage among prospective PAs and practicing PAs. The following chapters
will examine results of the survey, statistical analysis, discussion of the results, and ideas
for future studies associated with this research.
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Chapter Four: Results
Introduction
Chapter four contains the results of data analysis and is organized by demographic
information, research question responses, and statistical findings. The results section is
designed to answer the aforementioned research questions. Survey population
demographics are provided in written and graphical form for observation. This includes
gender, age, and group identity (pre-PA, PA-S didactic, PA-S clinical, PA-C in
practice). Similarly, caffeine use for academic, professional, and other purposes among
groups is provided in written and graphical form for observation. Differences in
frequency of caffeine use for academic, professional, and other purposes were analyzed
for statistical significance. Caffeine products are provided in written and graphical form
as a percentage of the total number of participants that responded to this question on the
survey. Finally, caffeine knowledge was divided and analyzed separately by benefits,
side effects, and withdrawal symptoms and among groups. Mean scores are recorded in
graphical from and comparison analysis between groups is described.
Survey Population
In total, 182 surveys were collected, and six were deleted due to
incompletion. For the most part, these particular participants answered the demographic
data questions but then failed to complete the section that assessed the level of knowledge
on caffeine; therefore, data was analyzed using 176 qualified surveys. Of the 176
surveys, 43 participants identified as male (24.4%) and 143 were female (75.6%). The
majority of participants were either in the 15 to 24-year-old group (43.2%) or the 25 to
34-year-old group (51.1%). This was followed by 35-44 (4.0%) and 45-54
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(1.7%). There were no participants in the 55-64 or 65+ age groups. Participation was
largely divided between pre-PA students (40.3%) and PA students in their didactic year
(33.5%). Fewer surveys were collected from PA students in their clinical year (16.5%)
and practicing PAs (9.7%). Reasoning for these results will be reviewed in chapter
five. These results are depicted below in simple graph form (Figures 1-3).

Figure 1. Participant Gender. Data was divided demographically by gender; 24.4 of the
participants identified as male and 76.6 percent identified as female.
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Figure 2. Participant Age. Data was divided demographically by age; the majority of
participants were either in the 15 to 24-year-old age group or the 25 to 34-year old age
group, at 43.2 percent and 51.1 percent, respectively.

Figure 3. Participant Group. Data was divided demographically by group, as listed
above. It was largely divided between pre-PA students (40.3%) and PA students in their
didactic year (33.5%). Fewer surveys were collected from students in their clinical year
or PAs in practice.
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Prevalence of Caffeine Use for Academic and Professional Purposes Based on
Group
The prevalence of caffeine use was divided into four main groups for analysis: no
caffeine use, caffeine use for academic purposes, caffeine use for professional purposes,
and caffeine use for other purposes. The research questions address caffeine use among
pre-PA students, PA students, and clinically practicing PAs for academic and
professional purposes; thus, caffeine use for other purposes will be addressed in a later
section. The survey defined academic purposes as the use of caffeine in order to lengthen
study time, stay awake during class, improve academic performance, and/or increase
efficiency on assignments and studying. The survey defined professional purposes as the
use of caffeine in order to stay awake while working with patients and completing
paperwork, improve work performance, and/or increase productivity on work-related
duties. The total number of respondents who answered “yes” to caffeine use on the
survey were asked to reply to reasons for use of caffeine. These answers were totaled
and reported as a percentage of the total number in each group that responded.
General caffeine use was high in every group. Among pre-PA students, only 1.4
percent reported no caffeine use; similarly, “no caffeine use” is low among PA students
in their didactic year (10.2 percent), PA students in their clinical year (10.3 percent) and
clinically practicing PAs (0 percent). As one might expect, as students left academia and
started their clinical year or professional practice, they indicated a decrease in caffeine
use for academic purposes and an increase in caffeine use for professional purposes. For
example, among pre-PA students 83.1 percent reported caffeine use for academic
purposes, compared to students in their didactic year (72.9 percent), clinical year (62.1
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percent), and clinically practicing PAs (5.9 percent). Among pre-PA students, 33.8
percent reported caffeine use for professional purposes compared to 15.3 percent of PA
students in their didactic year, 62.1 percent of PA students in their clinical year, and 58.8
percent of clinically practicing PAs.
These results are displayed below in Figure 4. Of note, some respondents did use
caffeine for both academic and professional purposes or for other purposes solely, which
is why the percentages do not sum to 100 percent.

Figure 4. Prevalence of Caffeine Use for Academic and Professional Purposes. Practicing
PAs drink significantly less caffeine for academic purposes than pre- PAs, PA students in
their didactic year and PA students in their clinical year. PA students in their clinical year
use caffeine significantly more for professional purposes that both Pre-PA students and
PAs in their didactic year.
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Prevalence of Caffeine Use for Other Purposes Based on Group
As mentioned previously, participants were able to indicate the use of caffeine for
purposes other than academic or professional purposes. These additional purposes were
to increase vigilance, for sport, for social reasons, to cure a hangover, and for the
taste. Again, the results are reported as a percentage of the total participants in each
group. A description of these purposes was located on the survey, as is as follows: sport
— to enhance performance, social — drinking coffee socially, hangovers — to recover
from heavy alcohol consumption, and taste — enjoying the taste of caffeine-related
products.
Among all groups, it was most common for participants to use caffeine for social
reasons and for taste. For example, 69 percent of pre-PA students use caffeine for social
reasons, compared to PA students in their didactic year (47.5 percent), PA students in
their clinical year (55.2 percent), and practicing PAs (70.6 percent). As many as 94
percent of clinically practicing PAs reported caffeine use for taste reasons. This was
similarly elevated among pre-PA students (77.5 percent), PA students in their didactic
year (67.8 percent), and PA students in their clinical year (67.8 percent). It was rare for
participants to report caffeine use as a means of curing a hangover. This ranged from 0
percent among clinically practicing PAs to 8.5 percent among PA students in their
didactic year. Full results are displayed in Figure 5. Of note, some respondents reported
use of caffeine for multiple other purposes, which is why the percentages do not add up
to 100 percent.
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Figure 5. Prevalence of Caffeine Use for Other Purposes. Data is expressed as percentage
of the total number of participants. Surprisingly, the largest percentage of participants
who used caffeine for taste was practicing PAs. However, participants could indicate
more than one reason for using caffeine, which explains why the total percentage was
over 100.
Frequency of Caffeine Use for Academic and Professional Purposes Based on Group
Participants indicated the frequency of their use of caffeine for academic and
professional purposes. The data analyzed using a one-way ANOVA indicated statistical
significance in the difference in frequency of caffeine use for academic purposes
(F(3,172) = 16.401 = p<.001) (Table 1). A Tukey post-hoc test revealed that practicing
PAs drink significantly less caffeine for academic purposes than pre-PAs (p<.001), PA
students in their didactic year (p<.001 ) and PA students in their clinical year
(p<.001). There is no significant difference in frequency of caffeine use between pre-
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PAs, PA students in their didactic year, and PA students in their clinical year (p>.05)
(Table 2).
One-way ANOVA also revealed statistical significance in the difference between
groups in the frequency of caffeine use for professional purposes (F(3,172)=8.982 = p<
.001) (Table 1). A Tukey post-hoc test revealed that PA students in their clinical year use
caffeine significantly more for professional purposes than both Pre-PA students and PA
students in their didactic year (p=.024) and (p<.001) respectively. The Tukey post hoc
test also revealed that practicing PAs use caffeine for professional purposes significantly
more than PA students in their didactic year (p=.003). There is no significant difference
in the use of caffeine between Pre-PA students and PA students in their didactic year (p
=.090), Pre PA students and practicing PAs (p=.167), or between PA students in their
clinical year and practicing PAs (p=.995) (Table 2).

Table 1. Frequency of Caffeine Use For Academic and Professional Purposes. This table
shows descriptive statistics for between groups and within groups, with significance
shown for between groups. P-values < .001 for both groups.

Frequency
Academic

Between
Groups
Within
Groups
Total
Frequency Between
Professional Groups
Within
Groups
Total

Sum of
Squares

df

29.402
37.813

172
175

34.460
39.858

172
175

8.411

5.398

3

3

Mean
Square

F

Sig.

2.804

16.401

.000

1.799

8.982

.000

.171

.200
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Table 2. Tukey Post-Hoc Mean Comparisons. This table shows the mean comparisons
from the Tukey Post-hoc test as well as significance.
Dependent
Variable
Frequency
For
Academic
Purpose

Group
Pre -PA
Didactic
Clinical
Practicing

Frequency
Pre-PA
For
Professional
Purpose
Didactic
Clinical
Practicing

Group
Didactic
Clinical
Practicing
Pre- PA
Clinical
Practicing
Pre- PA
Didactic
Practicing
Pre- PA
Didactic
Clinical
Didactic
Clinical
Practicing
Pre- PA
Clinical
Practicing
Pre- PA
Didactic
Practicing
Pre- PA
Didactic
Clinical

Mean
Difference
.102
.210
.772*
-.102
.108
.670*
-.210
-.108
.562*
-.772*
-.670*
-.562*
.185
-.283*
-.250
-.185
-.468*
-.436*
.283*
.468*
.032
.250
.436*
-.032

St. Error
.073
.091
.112
.073
.094
.114
.091
.094
.126
.112
.114
.126
.079
.099
.121
.079
.102
.123
.099
.102
.137
.121
.123
.137

Frequency of Caffeine Use for Other Purposes Based on Group

Sig.
.499
.100
.000
.499
.657
.000
.100
.657
.000
.000
.000
.000
.090
.024
;167
.090
.000
.003
.024
.000
.995
.167
.003
.995

In addition to indicating frequency of caffeine use for academic and professional
purposes, participants were also able to indicate their frequency of caffeine use for other
purposes including for increased vigilance, sport, social, to help with a hangover, and
because of the taste. A One-Way ANOVA showed no statistical significance in the
frequency of caffeine use for these purposes (p>.05).
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Most Commonly Used Caffeine Products Based on Group
The total number of respondents who answered “yes” to caffeine use on the
survey were asked to reply to what caffeine containing product(s) they use for academic
or professional purposes. Of the 166 participants that responded “yes” to caffeine use, 30
did not respond to this particular question resulting in missing data. The answers from
the remaining 143 surveys were totaled and reported as a percentage of the total number
in each group that responded to the question.
The caffeine products analyzed in this study included coffee, tea/iced tea, cool
drinks (such as Coke or Mountain Dew), energy concoctions, and energy drinks. Coffee
was by far the most commonly used caffeine product. Among pre-PA students, 92.31
percent reported use of coffee; frequency of coffee as a caffeine product was similar
among PA students in their didactic year (91.3 percent), PA students in their clinical year
(90.9 percent), and practicing PAs (90 percent). Tea/iced tea was the second most
commonly consumed caffeine product at 41.5 percent among pre-PA students, 45.7
percent among PA students in their didactic year, 45.5 percent among PA students in
their clinical year, and 60 percent among clinically practicing PAs. Rarely, participants
reported energy concoctions as a source of caffeine. Caffeine use from energy
concoctions ranged from 0 percent among clinically practicing PAs and PAs in their
clinical year to 4.35 percent among PA students in their didactic year. Full results are
displayed below in Figure 6. Of note, some respondents reported use of multiple caffeine
products, which is why the percentages do not sum to 100 percent.
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Figure 6. Most Commonly Used Caffeine Products Among Groups. Clearly, coffee is
the most commonly used caffeine product among all of the groups. There were no
clinically practicing PA participants who indicated using energy drinks or energy
concoctions for a caffeine source.
Caffeine Knowledge Based on Group
The survey scoring system is described in Appendix K. Participants were given
two scores for each of the three knowledge questions. The first score pertains to the
number of correct options selected and the second to the number of incorrect options
selected. One point was awarded for each correct response with a maximum score of five
for each question. The correct response scores were then categorized as follows: 0 =
without knowledge; 1 = very little knowledge; 2 = little knowledge; 3 = moderate
knowledge; 4 = good knowledge; and 5 = very good knowledge. For the second score,
one point was given for each incorrect response with a maximum score of five for each
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question. The incorrect response scores will be categorized as follows: 0 = very good
knowledge; 1 = good knowledge; 2 = moderate knowledge; 3 = little knowledge; 4 = very
little knowledge; and 5 = without knowledge.
The data was initially analyzed for normality. The data was not normal so a
Kruskal- Wallis test was performed on each of the six categories; benefits correct,
benefits incorrect, side-effects correct, side-effects incorrect, withdrawal symptoms
correct, and withdrawal symptoms incorrect. Extensive visual aide of caffeine
knowledge is depicted in tables 3 and 4 below (refer to Appendix L for additional visual
aide).

Table 3. Correct Benefit, Side Effect, and Withdrawal Response Scores. The table
depicts the occurrence of the scores (recorded as percentage) for each knowledge section.
PA students in their clinical year had significantly more knowledge on the benefits of
caffeine when compared to the three other groups. P-value = <0.001. There were no
other significant differences (p <0.05) between groups.
Group
Benefits
Side Effects
Withdrawal

Pre-PA
Didactic
Clinical
Practicing PA
Pre-PA
Didactic
Clinical
Practicing PA
Pre-PA
Didactic
Clinical
Practicing PA

Without
26.76
15.25
13.79
5.88
1.41
1.69
0
0
0
0
0
0

Very
Little

59.15
55.93
62.07
76.47
16.90
8.47
17.24
17.65
7.04
10.17
17.24
11.76

Little

Moderate

Good

11.26
20.34
20.69
11.76
16.90
22.03
27.59
17.65
11.27
10.17
0
0

1.41
5.08
0
0
21.13
16.95
34.48
29.41
15.49
18.64
31.03
23.53

1.41
3.39
0
5.88
18.31
28.81
10.34
23.53
30.99
22.03
13.79
35.29

Very
Good

0
0
3.45
0
25.35
22.03
10.34
11.76
35.21
38.98
37.93
29.41
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Table 4. Incorrect Benefit, Side Effect, and Withdrawal Response Scores. The table
depicts the occurrence of the scores (recorded as percentage) for each knowledge section.
There were no significant differences (p <0.05) between groups.
Group
Benefits
Side Effects
Withdrawal

Pre-PA
Didactic
Clinical
Practicing PA
Pre-PA
Didactic
Clinical
Practicing PA
Pre-PA
Didactic
Clinical
Practicing PA

Without Very
Little
0
0
0
0
0
0
0
0
1.41
0
0
0

2.82
0
0
0
0
0
0
0
0
0
0
0

Little
0
0
0
0
11.76
5.08
6.90
11.76
1.41
5.08
0
5.88

Moderate

Good

5.63
6.78
10.34
11.76
8.45
20.34
17.24
5.88
7.04
8.47
20.69
11.76

47.89
38.98
44.83
29.41
42.25
42.37
41.38
41.18
38.03
40.68
27.59
17.65

Nearly all of the data was statistically insignificant (p > .05) except for one

Very
Good

43.67
54.24
44.83
58.82
46.48
32.30
34.48
41.18
52.11
45.76
51.72
64.71

category. The PA students in their clinical year had significantly more “very good”
knowledge (p < .001) on the benefits of caffeine when compared to the other three groups
(Table 5 and 6). There was no significant difference in the other five levels of
knowledge.

Table 5. Correct Benefit Response Kruskall-Wallis. P-value = <0.001.

Chi- Square
df
Asymp. Sig.

Without Very Little
5.746
3
.125

2.388
3
.496

Little

2.707
3
.439

Moderate
3.390
3
.335

Good

2.229
3
.526

Very Good
175.000
3
.000

47
Table 6. Correct Benefit Response Mean Ranks. This table depicts that the PA students in
their clinic year have significantly more knowledge of the benefits of caffeine when
compared to the three other groups.
Without
Knowledge
Very Little
Knowledge
Little
Knowledge
Moderate
Knowledge
Good
Knowledge
Very Good
Knowledge

Summary

Group
Pre- PA
Didactic
Clinical
Practicing
Total
Pre-PA
Didactic
Clinical
Practicing
Total
Pre-PA
Didactic
Clinical
Practicing
Total
Pre-PA
Didactic
Clinical
Practicing
Total
Pre-PA
Didactic
Clinical
Practicing
Total
Pre- PA
Didactic
Clinical
Practicing
Total

N
71
59
29
17
176
71
59
29
17
176
71
59
29
17
176
71
59
29
17
176
71
59
29
17
176
71
59
29
17
176

Mean Rank
95.55
85.42
84.14
77.18
87.56
84.72
90.12
102.79
84.42
92.40
92.71
84.85
87.74
90.97
86.50
86.50
87.74
89.49
86.50
91.68

74.00
74.00
162.00*
74.00

This chapter contained the results of data analysis. Of the 176 surveys, 43
participants identified as male (24.4%) and 143 were female (75.6%). Participation was
largely divided between pre-PA students (40.3%) and PA students in their didactic year
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(33.5%). Fewer surveys were collected from PA students in their clinical year (16.5%)
and practicing PAs (9.7%).
Prevalence of caffeine use was divided for analysis between academic and
professional purposes and caffeine use for other purposes. Various percentages were
reported to indicate whether or not the separate groups used caffeine or not and for what
purposes participants in each of these groups were using caffeine.
An ANOVA test was used to determine the difference in the frequency of caffeine
use for academic purposes between Pre- PA students, PA students in their didactic year,
PA students in their clinical year, and practicing PAs. The ANOVA was significant, and
a Tukey’s post-hoc was performed to determine how it was significant. The Tukey’s
post-hoc test revealed that practicing PAs used caffeine for academic purposes
significantly less than the other three groups (p < .001). There was no difference in
caffeine use between pre-PAs, PA students in their didactic year, and PA students in their
clinical year.
ANOVA and a Tukey’s post-hoc were also performed to determine the difference
of caffeine use between each group for professional purposes. Tukey’s post-hoc test
revealed that PA students in their clinical year use caffeine significantly more for
professional purposes that both Pre-PA students and PAs in their didactic year (p=.024)
and (p<.001) respectively and practicing PAs use caffeine significantly more frequently
than PAs in their didactic year (p=.003). There is no significant difference in the use of
caffeine between Pre-PA students and PA students in their didactic year (p =.090), Pre
PA students and practicing PAs (p=.167), or between PA students in their clinical year
and practicing PAs (p=.995).
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Finally a Kruskall-Wallis test was used to analyze the data on the knowledge
benefits, side effects, and withdrawal symptoms of caffeine between pre-PAs, PA
students in their didactic year, PA students in their clinical year, and practicing PAs. The
Kruskall-Wallis test revealed that the PA students in their clinical year had significantly
more knowledge (p < .001) on the benefits of caffeine when compared to the other three
groups. The rest of the analyses were insignificant with p values > .05. Chapter 5
provides interpretation and conclusions made from of all the results noted in chapter 4.
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Chapter Five: Discussion and Conclusions
Introduction
This chapter draws conclusions from the data analysis. The project sought to
determine the frequency of caffeine use for academic and professional purposes and then
assess the level of knowledge on caffeine among the four participant groups. Level of
knowledge was based on correct and incorrect responses on the survey questions that
asked about the benefits, side effects, and withdrawal symptoms of caffeine.
Demographic Data
The average participant of the study’s sample of 176 participants was a female
between the ages of 15-34. Of the 176 participants, only 46 were PA students in their
clinical year or clinically practicing PAs, which leaves 130 participants who were either
pre-PA students or PA students in their didactic year. Given that the average PA student
is 27 years old and female (Pasquini 2015), the data reflects national trends as a
whole. Additionally, data was collected via a paper copy in person from Bethel pre-PA
students and Bethel PA students in their didactic year, whereas the remainder of
participants responded to the online survey. This method of collection resulted in a
higher percentage of pre-PA students and PA students in their didactic year, which skews
the data.
Prevalence of Caffeine Use for Academic and Professional Purposes
For analysis, the results from the survey were summarized as no caffeine, caffeine
use for academic purposes, and caffeine use for professional purposes. In general,
caffeine use was high among all groups, with the highest percentage of “no caffeine use”
being among PA students in their clinical year (10.3 percent). As one might expect,
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caffeine use for academic purposes decreased as students left the academic, or didactic,
phase of school and began in the clinical phase or began practicing. For example, 83.1
percent of pre-PA students and 72.9 percent PA-students in their didactic year reported
caffeine use for academic purposes. This percentage was much decreased in clinically
practicing PAs, who reported only 5.9 percent of caffeine use for academic purposes.
Finally, caffeine use for professional purposes increased as students left the
academic phase and began practicing in a professional environment; only 33.8 percent of
pre-PA students reported caffeine use for professional purposes. Interestingly, 62.1
percent of PA students in their clinical year reported caffeine use for professional
purposes, likely indicating a professional component to most clinical phases of PA
school. In Lee et. al’s study, 93.6 percent of participants reported caffeine use, indicating
that caffeine remains one of the most commonly used substances in the world.
Unfortunately, Lee et. al’s study did not find similar trends in caffeine use for
academic/professional purposes as students progressed in their studies. For example,
first-year medical students reported the lowest caffeine use for academic purposes when
compared to second and third year students (Lee et. al 2009). Clear conclusions cannot
be drawn from our study, as they aren’t adequately backed up by previous studies;
however, it seems acceptable to assume that caffeine is used rampantly in academic and
professional situations.
Prevalence of Caffeine Use for Other Purposes
Among all groups, it was most common for participants to use caffeine for social
reasons or for taste. In fact, 67.8 percent (PA-didactic, PA-clinical) to 94 percent
(practicing PAs) of participants indicated use because they enjoyed the taste. Because
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participants could choose multiple reasons for caffeine use, it is likely that these
participants used caffeine for academic/professional purposes and because they enjoyed
the taste. Additionally, caffeine can be prepared in multiple ways, suggesting that a wide
variety of caffeine taste preferences contributed to this value. An average of 60.6 percent
of participants indicated caffeine use for social reasons. This value does not correlate as
well with academic/professional purposes, as these might not be social situations and are
more likely school or work related. Similar findings were found in Lee et al.’s study, as
preference for taste and social were the most common reasons chosen by all of the
participants (Lee et. al 2009).
Frequency of Caffeine Use for Academic and Professional Purposes
A one-way ANOVA indicated statistical significance in the difference in
frequency of caffeine use between groups for both academic and professional
purposes. A Tukey post-hoc test revealed that practicing PAs use significantly less
caffeine for academic purposes than all other groups (p<0.001), while there was no
significant difference between the three remaining groups. As mentioned above, one
would expect the use of caffeine for academic purposes to decrease as participants leave
academia and move forward into practice. While the percentages reflect this trend, there
was only statistical significance in the case of practicing PAs.
A Tukey post-hoc test revealed that PA students in their clinical year use caffeine
for professional purposes significantly more than both pre-PA students (p=.024) and PA
students in their didactic year (p<.001). In addition, the research found that practicing
PAs use caffeine for professional purposes significantly more than PA students in their
didactic year (p=.003). No significant difference was noted in comparison between the
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remaining groups. Over half of the PA students in their clinical year reported caffeine
use for professional purposes, likely indicating a professional component to most clinical
phases of PA school. Interestingly, there was no significance in the use of caffeine for
professional purposes between practicing PAs and pre-PA students. This finding is likely
explained by the skew in numbers of responses between the two groups (17 practicing
PAs versus 71 pre-PA students). In addition, it is probable that pre-PA students
responded using caffeine for professional purposes based on previous professional
experience prior to PA school.
Most Commonly Used Caffeine Products
Multiple caffeine products were analyzed in this study, including coffee, tea/iced
tea, cool drinks, energy concoctions, and energy drinks. Over 90 percent of participants
in all four groups indicated coffee as a caffeine product used, demonstrating that coffee is
the most commonly used product. This percentage is reflective of Lee et. al’s study, in
which coffee was the most commonly consumed product at 88.2 percent. Among the four
research groups, an average of 48.2 percent of participants reported the tea/iced tea as a
means of caffeine use. This value was much higher in this study when compared to Lee
et. al’s study, which indicated energy mixtures as the second most commonly used
caffeine product (37.9 percent) (Lee et al. 2009). In this study, few participants indicated
that they used energy mixtures as a caffeine product. These findings can potentially be
attributed to the fact that coffee is one of the most readily available and cheapest forms of
caffeine.
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Participants’ Knowledge on Caffeine
The following research question was addressed in this section: What is the level
of knowledge among these individuals on the benefits, side effects, and withdrawal
symptoms of caffeine?
A Kruskall Wallis test was performed on the data in this section. High p-values
were obtained for five out of the six areas addressed including incorrect benefits of
caffeine, correct side effects, incorrect side effects, correct withdrawal symptoms, and
incorrect withdrawal symptoms. A significant p-value (p < .001) was obtained for
correct knowledge of the benefits of caffeine. PA students in their clinical year had
significantly more “very good” knowledge on the benefits of caffeine when compared to
pre-PA students, PA students in their didactic year, and practicing PAs. No significant
difference was found in the other levels of knowledge on the benefits of caffeine.
This significance may be skewed. Only one out of the 29 PA students in their
clinical year scored “very good” on the benefits of caffeine. Technically, this is equal to
three percent, as compared to pre-PA students, PA students in their didactic year, and
practicing PAs, who scored zero percent in the category of “very good” on the benefits of
caffeine. While three percent versus zero percent may be statically significant per the
Kruskall-Wallis test, there was still only one person overall who had very good
knowledge on the benefits of caffeine. Overall, it can be concluded that there is a lack in
knowledge on the benefits of caffeine.
Data in the current study was analyzed differently from the data in the example
study conducted by Lee et al. (2009); therefore, the results on knowledge cannot be
adequately compared. The study by Lee et al. scored their results on a scale of 1-5; 0 =
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without knowledge; 1 = very little knowledge; 2 = little knowledge; 3 = moderate
knowledge; 4-5 = good knowledge. The average score for first, second, and third year
medical student were then analyzed using a Kruskall-Wallis test.
The current study took this analysis one step further. The researchers decided that
accurate knowledge was better described by comparing both answers correct and answers
incorrect. This scoring system helped decrease the potential of a high score of correct
knowledge by purely guessing or marking all the options on the survey as correct. In Lee
et al.’s study, participants could theoretically mark all options in the benefits, side effects,
and withdrawal symptoms; by doing so, they would guess the correct options by default.
The current study attempted to lessen a high score due to guessing by deducting points
for incorrect answers.
Limitations
This study had various limitations. One limitation being there was no control
over the response rate of the survey. Pre-PA students had the highest response rate of 71
participants, while practicing PAs only had a response rate of 17 participants. Paper
copies of the survey were given to Bethel University Pre-PA students and PA students in
their didactic year, while an online version of was sent out to all other participants.
Because of this, there was likely a higher response rate from the students from Bethel. It
is likely that there was a lower response rate to the surveys sent out in email. This could
be due to large volume of emails that are sent out in a day. The email can get lost,
disregarded, or sent to spam. All participants were given the opportunity to decline the
survey, regardless of whether the survey was given in person or via email.
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Overall, 40 participants were needed in each group to have true statistical
significance. This number of participants is also a limitation in the study as the
researches did not have 40 participants in each group. There were 71 pre- PA students, 59
PA students in their didactic year, 29 PA students in their clinical year, and 17 practicing
PAs. A larger and equal sample size among all groups would have provided a more
accurate representation on the comparison of knowledge between groups.
One delimitation of the study was that subjects were intentionally limited to prePA students, current PA students, and practicing PAs in the state of Minnesota. In
addition, practicing PAs were limited to those who graduated from Augsburg College,
Bethel University, or St. Catherine University within the past five years. Therefore, the
results of this research cannot be extended to the national PA population. The results also
cannot be extended to practicing PAs who graduated from a Minnesota school more than
five years ago.
Recommendations for Further Research
For means of future research, the researchers recommend larger sample size with
a special focus on equal sample sizes between each of the research groups. There was a
large range in the number of participants in each group (71 pre-PA students versus 17
practicing PAs), which likely skewed the results toward a specific population. Having
equal numbers of participants in these groups would avoid this. Additionally, students
came from various schools and participants were not required to indicate where they
attended school. Although the researchers did not make a comparison between schools,
the data could have been skewed if a larger number of students came from a certain
school.
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For further research, it would be interesting to compare caffeine use and
knowledge among various professional, such as PAs, nurses, MDs, PTs, OTs, and
pharmacists. This comparison would require intense surveying of various professionals
in various medical settings and would be difficult to do. However, it would add to the
current study that was limited to the PA profession.
Additionally, future research should note which benefits, side effects, and
withdrawal symptoms were answered incorrectly most often. This comparison was made
in Lee et. al’s study, and it would further the conclusion that little is known about
caffeine, despite it being a highly used product.
Conclusions
Based on the available data, the use of caffeine for academic and professional
purposes was analyzed with the survey instrument. Participants in the academic phase of
school used caffeine for academic purposes when compared to those out in practice. For
example, 83.1 percent of pre-PA students, 72.9 percent PA-students in their didactic year,
and 62.1 percent of students in their clinical year used caffeine for academic purposes. In
contrast, only 5.9 percent of clinically practicing PAs reported caffeine use for academic
purposes. Caffeine use for professional purposes increased as students left the academic
phase and began practicing in a professional environment; only 33.8 percent of pre-PA
students reported caffeine use for professional purposes, while 59 percent of clinically
practicing PAs used caffeine for professional purposes.
Frequency of caffeine use for academic and professional purposes was also
analyzed. One-way ANOVA indicated statistical significance in the difference in
frequency of caffeine use for academic purposes. Tukey post-hoc test revealed that
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clinically practicing PAs used caffeine for academic purposes significantly less than the
other three groups. One-way ANOVA also revealed statistical significance in the
difference between groups in the frequency of caffeine use for professional purposes.
Tukey post-hoc revealed that PA students in their clinical year use caffeine significantly
more for professional purposes that both Pre-PA students and PAs in their didactic year.
Practicing PAs use caffeine significantly more than PAs in their didactic year. No other
significance was found in caffeine use between groups for professional purposes.
Kruskall-Wallis was used to analyze the knowledge on the benefits, side- effects,
and withdrawal symptoms of caffeine. This test revealed that PA students in their
clinical year had significantly more knowledge (p < .001) on the benefits of caffeine
when compared to the other three groups. All other analyses were insignificant.
A high percentage of participants indicated that they use caffeine; however,
overall scores on the knowledge of caffeine benefits, side effects, and withdrawal
symptoms were relatively low. This result may indicate that many participants were using
caffeine without having sufficient knowledge of its benefits, side effects and withdrawal
symptoms, and further education is necessary. The current study was limited in
demographics and sample size. Further research is needed to improve and add onto the
current study.
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Appendix G: Initial Correspondence Email
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Hello,
We are first year students in Bethel University’s Physician Assistant program. We
contacted you earlier this year to get approval for your students and recent graduates to
participate in our study. The study will assess participants’ use of caffeine and their
knowledge on the benefits, side effects, and withdrawal symptoms of caffeine. Attached
to this email is a link to the online survey. Can you please distribute the content below,
with the survey link included, to your current clinical year students and your recent
graduates (within the past 5 years, if applicable)?
This study is being conducted by first year students in Bethel University’s Physician
Assistant program. The following survey will assess the participant’s knowledge on the
benefits, side effects, and withdrawal symptoms of caffeine. It should take no longer
than 5 to 10 minutes to complete. You will not be asked about any personal information
and only the researchers and their committee will have access to submitted data. You are
NOT required participate in this survey. Should you choose to participate, your signature
on the letter of informed consent will serve as an acknowledgement that submission of
your survey indicates release of data for professional use.
Survey link:
Thank you for your time. Please let us know if you have any questions or concerns.
Thank you,
Kjerstin Dennis, Chelsie Manton, Greta Sowles
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Dear Pre-Physician Assistant, Physician Assistant Student, or Physician Assistant:

We are three physician assistant students from Bethel University conducting
research in partial fulfillment of the requirements for a Masters Degree in Physician
Assistant Studies. Our study is investigating the use of caffeine among pre-physician
assistant students, current physician assistant students, and practicing physician
assistants and their knowledge about caffeine’s benefits, side effects, and
withdrawal symptoms. Bethel IRB approval was obtained to implement this study.

Attached is a survey to gather necessary information to complete the data collection
of this research. You are NOT required to participate in this survey. Should you
choose to participate, the survey will take approximately 10-15 minutes to
complete. By completing this survey, you are indicating informed consent to
participate in this study. Reports and subsequent data will not discuss individual
responses, but will include only group data. Your identity will not be collected.

We understand that you have an extremely busy schedule and your time is limited.
Please realize that your participation is vital to the success of this research. The
information that you provide is essential to the validity of this study. Thank you in
advance for your prompt response. Please complete the survey by June 6, 2016. If
you have any questions, please contact Chelsie Manton at 218-316-4047 or Wallace
Boeve at 651-308-1398.
Thank you again for your help.
Sincerely,

Greta Sowles, Chelsie Manton, and Kjerstin Dennis
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Hello,
We are first year students in Bethel University’s Physician Assistant program. We
contacted you recently about distributing the survey link below. Can you please
distribute the content below, with the survey link included, to your current clinical year
students and your recent graduates (within the past 5 years, if applicable) to serve as a
reminder to complete the survey?
This study is being conducted by first year students in Bethel University’s Physician
Assistant program. The following survey will assess the participant’s knowledge on the
benefits, side effects, and withdrawal symptoms of caffeine. It should take no longer
than 5 to 10 minutes to complete. You will not be asked about any personal information
and only the researchers and their committee will have access to submitted data. You are
NOT required participate in this survey. Should you choose to participate, your signature
on the letter of informed consent will serve as an acknowledgement that submission of
your survey indicates release of data for professional use.
Survey link:
Thank you for your time. Please let us know if you have any questions or concerns.
Thank you,
Kjerstin Dennis, Chelsie Manton, Greta Sowles
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Appendix K: Survey Grading Rubric
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Survey Grading Rubric
Question 9- Benefits:
•

•
•

The participant will be given two scores for this question. The first score will
pertain to the number of correct options selected and the second will pertain to the
number of incorrect options selected. For each correct response the participant
will receive 1 point (maximum of 5 points) towards their first score. For each
incorrect response the participant will receive 1 point (maximum of 5 points)
towards their second score. No points will be given or subtracted for answers that
go unmarked.
Correct options include: increases vigilance, prevents type 2 Diabetes Mellitus,
Prevents Parkinson’s disease, increases long-term memory, and prevents
Alzheimer’s disease.
Incorrect options include: substitute for sleep, increases alcohol tolerance,
increases short-term memory, prevents erectile dysfunction, and slows down
metabolism.

Question 10- Side effects:
•

•
•

The participant will be given two scores for this question. The first score will
pertain to the number of correct options selected and the second will pertain to the
number of incorrect options selected. For each correct response the participant
will receive 1 point (maximum of 5 points) towards their first score. For each
incorrect response the participant will receive 1 point (maximum of 5 points)
towards their second score. No points will be given or subtracted for answers that
go unmarked.
Correct options include: increases cardiac output, increases force of heart, rapid
beating of the heart, increases sleep disturbances, and increases respiration rate.
Incorrect options include: dry eyes, hot flushes, erectile dysfunction, slow beating
of the heart, and acne.

Question 11- Withdrawal symptoms:
•

•

The participant will be given two scores for this question. The first score will
pertain to the number of correct options selected and the second will pertain to the
number of incorrect options selected. For each correct response the participant
will receive 1 point (maximum of 5 points) towards their first score. For each
incorrect response the participant will receive 1 point (maximum of 5 points)
towards their second score. No points will be given or subtracted for answers that
go unmarked.
Correct options include: headache, fatigue, increases mood disturbance, decreases
alertness, and drowsiness.
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•

Incorrect options include: nasal congestion, increases alcohol tolerance,
forgetfulness, hallucinations, and aggression.

The highest score one can get on any of the above questions is 5 and the lowest score is 0.
Scores will be kept separate for each question and the participants’ scores will be
categorized as follows:
Correct Response Score
0 = without knowledge
1 = very little knowledge
2 = little knowledge
3 = moderate knowledge
4 = good knowledge
5 = very good knowledge

Incorrect Response Score
0 = very good knowledge
1 = good knowledge
2 = moderate knowledge
3 = little knowledge
4 = very little knowledge
5 = without knowledge
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Appendix L: Knowledge Graphs
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Figure 7. Correct Benefit Response Scores. The figure depicts the occurrence of the
number of correct responses about the benefits of caffeine among groups. PA students in
their clinical year had significantly more knowledge on the benefits of caffeine when
compared to the three other groups. P-value = <0.001.

Figure 8. Incorrect Benefit Response Scores. The figure depicts the occurrence of the
number of incorrect responses about the benefits of caffeine among all groups. There
were no significant differences (p < 0.05) among groups.
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Figure 9. Correct Side Effect Response Scores. This figure depicts the occurrence of the
number of correct responses on the side effects of caffeine among all groups. There were
no significant differences (p <0.05) between groups.

Figure 10. Incorrect Side Effect Response Scores. This figure depicts the occurrence of
the number of incorrect responses on the side effects of caffeine among all groups. There
were no significant differences (p < 0.05) among groups.
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Figure 11. Correct Withdrawal Response Scores. This figure depicts the occurrence of
the number of correct responses on the withdrawal symptoms of caffeine among all
groups. There were no significant differences (p < 0.05) among groups.

Figure 12. Incorrect Withdrawal Response Scores. This figure depicts the occurrence of
the number of incorrect responses on the withdrawal symptoms of caffeine among all
groups. There were no significant differences (p < 0.05) among groups.

